Trademarkia Logo

Canada

C$
Trademark Search in Canada
MODERNA LIFE SCIENCES

View On IC.GC.CA

MODERNA LIFE SCIENCES
REGISTERED

on 21 Dec 2022

Last Applicant/ Owned by

MODERNATX INC.

325 Binney StreetCambridge, MA 02142

US

Serial Number

2029996 filed on 22nd May 2020

Registration Number

TMA1157171 registered on 21st Dec 2022

Registration expiry Date

21st Dec 2032

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

CA

K1P5Y6

MODERNA LIFE SCIENCES

Trademark usage description

biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific resea Read More

Classification Information

Class [001]
Biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific research and medical research; biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancers, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for medical-scientific research use; chemicals for use in biotherapeutics, biosimilars and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use.

Classification kind code

11

Class [005]
Medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating cancers, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of cancers, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, reproductive disorders, neurological disorders, namely, Alzheimer's disease, Multiple sclerosis, Amyotrophic Lateral Sclerosis, ataxia, brain injury, pain, motor neuron disease, spinal cord injury, Parkinson's disease, stroke, epilepsy and neuropathy, and the prevention and treatment of rare diseases, namely, Cystic fibrosis, Methylmalonic acidemia, Propionic acidemia, Phenylketonuria, Ornithine transcarbamylase deficiency, Maple syrup urine disease, Arginase-1 deficiency, Factor VIII deficiency, Glycogen storage disorder type 1a, Adult-onset type II citrullinemia and Progressive familial intrahepatic cholestasis type; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagents; vaccines for human use.

Classification kind code

11

Class [042]
Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutic drugs; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids.

Classification kind code

11

Mark Details

Serial Number

2029996

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 67
on 7th Oct 2022		Agent Name Changed
Submitted for opposition 42
on 28th Sept 2022		Advertised
Submitted for opposition 27
on 30th Aug 2022		Approval Notice Sent
Submitted for opposition 26
on 30th Aug 2022		Approved
Submitted for opposition 48
on 12th Jan 2022		Agent Changed
Submitted for opposition 22
on 23rd Sept 2021		Search Recorded
Submitted for opposition 20
on 23rd Sept 2021		Examiner's First Report
Submitted for opposition 30
on 22nd May 2020		Filed
Submitted for opposition 1
on 22nd May 2020		Created
Submitted for opposition 31
on 22nd May 2020		Formalized